Browse By:

Search News Room

News Room: Drugs

Theravance to Present at Investor Conferences in June 2013

SOUTH SAN FRANCISCO, CA--(Marketwired - May 23, 2013) - Theravance, Inc. (NASDAQ: THRX) announced today that Rick E Winningham, Theravance's Chief Executive Officer, is scheduled to present at...(more)

Theravance, Inc.
May 23, 2013 16:05 ET

College of Pharmacy Partners With TNI BioTech to Develop New Drugs for Africa

WASHINGTON, DC--(Marketwired - May 23, 2013) - Howard University College of Pharmacy has signed a multi-year agreement with TNI BioTech, Inc. (OTCQB: TNIB), a Bethesda, Md., biotech firm that...(more)

TNI BioTech, Inc.
May 23, 2013 09:56 ET

BrainStorm Announces CEO Interview With The Wall Street Analyst

NEW YORK, NY and PETACH TIKVAH, ISRAEL--(Marketwired - May 23, 2013) - BrainStorm Cell Therapeutics (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative...(more)

BrainStorm Cell Therapeutics, Inc.
May 23, 2013 09:52 ET

Cynapsus Therapeutics Reports First Quarter 2013 Financial Results and Recent Developments

TORONTO, ONTARIO--(Marketwired - May 23, 2013) - Cynapsus Therapeutics Inc. (TSX VENTURE:CTH), developing the only non-injectable (i.e. sublingual) delivery of the only approved drug...(more)

Cynapsus Therapeutics Inc.
May 23, 2013 09:28 ET

Un nouveau rapport confirme que les investissements de l'industrie pharmaceutique innovatrice au Canada sont systématiquement sous-évalués

OTTAWA, ONTARIO--(Marketwired - 23 mai 2013) - Pour la troisième année consécutive, une étude de KPMG commandée par Rx&D - Les compagnies de recherche pharmaceutique du Canada, a...(more)

Les compagnies de recherche pharmaceutique du Canada
May 23, 2013 08:12 ET

New Report Confirms Innovative Pharmaceutical Sector's Investment in Canada is Chronically Underreported

OTTAWA, ONTARIO--(Marketwired - May 23, 2013) - For the third consecutive year, a KPMG study commissioned by Canada's Research-Based Pharmaceutical Companies (Rx&D) has determined that...(more)

Canada's Research-Based Pharmaceutical Companies
May 23, 2013 08:12 ET

Soricimed Biopharma Inc. annonce l'essai clinique de phase 1 aux Etats-Unis du SOR-C13, un nouveau médicament contre le cancer

TORONTO, ONTARIO--(Marketwired - 23 mai 2013) - Soricimed Biopharma Inc., une société privée qui se spécialise dans les essais cliniques et qui met au point de nouveaux produits...(more)

Soricimed Biopharma Inc.
May 23, 2013 07:30 ET

Soricimed Biopharma Inc. Announces U.S. Trial Site for Phase I Clinical Trial of New Cancer Drug, SOR-C13

TORONTO, ONTARIO--(Marketwired - May 23, 2013) - Editors Note: There is a photo associated with this press release. Soricimed Biopharma Inc., a private clinical stage...(more)

Soricimed Biopharma Inc.
May 23, 2013 07:30 ET

Flamel Technologies Obtains Rights to Two Molecules of Trigger Lock Product Line

LYON, FRANCE--(Marketwired - May 23, 2013) - Flamel Technologies (NASDAQ: FLML) today announced that it has exercised its right to regain control of two drugs that use its Trigger Lock™ delivery...(more)

Flamel Technologies
May 23, 2013 07:30 ET

Second Annual 'Clinical Research in Georgia' Conference Set for December 4th, 2013

ATLANTA, GA--(Marketwired - May 23, 2013) - The second annual Clinical Research in Georgia Conference will be held on December 4th, 2013, at the Academy of Medicine in the heart of midtown...(more)

Clinical Research in Georgia Conference
May 23, 2013 06:48 ET

US: 1.800.774_.9473
Canada: 1.888.299_.0338
UK: +44.20.7220_.4500

Follow Marketwired